• DESLANOSIDE CHEMBL1614 FDA Approved

    Alternate Names:

    Deslanoside
    Desacetyl-Lanatoside C
    Cedilanid-D
    17598-65-1
    Glucodigoxin
    Deslanosidum
    Deslanosido
    Desacetyllanatoside C
    Deacetyllanatoside C
    3-[(O-beta-D-Glucopyranosyl-(1->4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxy-3beta,5beta,12beta-card-20(22)-enolide
    (3beta,5beta,12beta)-3-{[beta-D-glucopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide
    DB01078
    CA006475
    NCGC00159441-03
    TOX21_111671_1
    DAP000464
    C47H74O19
    8100AH
    TOX21_111671
    OBATZBGFDSVCJD-LALPQLPRSA-N
    MOLPORT-006-122-280
    DESLANOSIDE (JP16/USP/INN)
    DESLANOSIDE (JP15/USP/INN)
    YGY317RK75
    GTPL6806
    SCHEMBL125311
    CID28620
    NCGC00159441-02
    CEDILANIDEREG
    CAS-17598-65-1
    3BETA-{[BETA-D-GLUCOPYRANOSYL-(1->4)-2,6-DIDEOXY-BETA-D-RIBO-HEXOPYRANOSYL-(1->4)-2,6-DIDEOXY-BETA-D-RIBO-HEXOPYRANOSYL-(1->4)-2,6-DIDEOXY-BETA-D-RIBO-HEXOPYRANOSYL]OXY}-12BETA,14-DIHYDROXY-5BETA-CARD-20(22)-ENOLIDE
    3BETA-(O-BETA-D-GLUCOPYRANOSYL-(1-4)-O-BETA-D-DIGITOXOSYL-(1-4)-O-BETA-D-DIGITOXOSYL-(1-4)-BETA-D-DIGITOXOSYLOXY=12BETA.14=DIHYDROXY-5BETA,14BETA-CARD-20(22)-ENOLID
    3BETA-(O-BETA-D-GLUCOPYRANOSYL-(1-4)-O-BETA-D-DIGITOXOSYL-(1-4)-O-BETA-D-DIGITOXOSYL-(1-4)-BETA-D-DIGITOXOSYLOXY-12BETA,14-DIHYDROXY-5BETA,14BETA-CARD-20(22)-ENOLID
    35-58-5
    1329-81-3
    11029-69-9
    11004-41-4
    CARD-20(22)-ENOLIDE, 3-((O-BETA-D-GLUCOPYRANOSYL-(1-4)-O-2,6-DIDEOXY-BETA-D-RIBO-HEXOPYRANOSYL-(1-4)-O-2,6-DIDEOXY-BETA-D-RIBO-HEXOPYRANOSYL-(1-4)-2,6-DIDEOXY-BETA-D-RIBO-HEXOPYRANOSYL)OXY)-12,14-DIHYDROXY-, (3BETA,5BETA,12BETA)-
    CARD-20(22)-ENOLIDE, 3-((O-BETA-D-GLUCOPYRANOSYL-(1->4)-O-2,6-DIDEOXY-BETA-D-RIBO-HEXOPYRANOSYL-(1->4)-O-2,6-DIDEOXY-BETA-D-RIBO-HEXOPYRANOSYL-(1->4)-2,6-DIDEOXY-BETA-D-RIBO-HEXOPYRANOSYL)OXY)-12,14-DIHYDROXY-, (3BETA,5BETA,12BETA)-
    4-18-00-02455 (BEILSTEIN HANDBOOK REFERENCE)
    DSSTOX_GSID_22897
    DSSTOX_RID_76778
    D01240
    DSSTOX_CID_2897
    LS-87553
    DESLANOSIDE [USAN:BAN:INN:JAN]
    AMBAP17598-65-1
    BRN 0078187
    EINECS 241-568-1
    AC1L1FPG
    CHEBI:31468
    UNII-YGY317RK75
    DESLANOSIDO [INN-SPANISH]
    DESLANOSIDUM [INN-LATIN]
    LANATOSIDE C, DEACETYL-
    DESACETYLDIGILANIDE C
    CEDILANID-D (TN)
    DESACETYL LANATOSIDE
    LANATOSID C
    DESLANOSIDUM C
    DESACE
    SEDIRANIDO
    LEKOZID
    CEGLUNAT
    28620
    DESLANATOSIDE C
    443932
    3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-12,14-DIHYDROXY-3-[(2R,4S,5S,6R)-4-HYDROXY-5-[(2S,4S,5S,6R)-4-HYDROXY-5-[(2S,4S,5S,6R)-4-HYDROXY-6-METHYL-5-[(2S,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL]OXYOXAN-2-YL]OXY-6-METHYLOXAN-2-YL]OXY-6-METHYLOXAN-2-YL]OXY-10,13-DIMETHYL-1,2,3,4,5,6,7,8,9,11,12,15,16,17-TETRADECAHYDROCYCLOPENTA[A]PHENANTHREN-17-YL]-2H-FURAN-5-ONE
    7848303
    178103412
    6806

    Drug Info:

    Drug Categories therapeutic uses
    Drug Categories steroids
    Drug Categories specialty uses of chemicals
    Drug Categories protective agents
    Drug Categories polycyclic compounds
    Drug Categories physiological effects of drugs
    Drug Categories pharmacologic actions
    Drug Categories molecular mechanisms of pharmacological action
    Drug Categories lanatosides
    Drug Categories glycosides
    Drug Categories enzyme inhibitors
    Drug Categories digitalis glycosides
    Drug Categories chemical actions and uses
    Drug Categories cardiovascular system
    Drug Categories cardiovascular agents
    Drug Categories cardiotonic agents
    Drug Categories cardiac therapy
    Drug Categories cardiac glycosides
    Drug Categories cardenolides
    Drug Categories cardanolides
    Drug Categories carbohydrates
    Drug Categories anti-arrhythmia agents
    Drug Groups approved
    Drug Type small molecule
    FDA Approval Approved before 1982
    Drug Class small molecule
    Drug Indications Cardiotonic Agents
    Drug Indications Antiarrhythmia Agents
    Year of Approval approved before 1982
    Drug Class anti-arrhythmia agents
    Drug Class cardiotonic agents
    (3 More Sources)
    • Version: 5.0.8

    Alternate Names:
    DESLANOSIDE DrugBank Drug Name
    (3beta,5beta,12beta)-3-{[beta-D-glucopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide Drug Synonym
    3-[(O-beta-D-Glucopyranosyl-(1->4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxy-3beta,5beta,12beta-card-20(22)-enolide Drug Synonym

    Drug Info:
    Drug Type small molecule
    Drug Groups approved
    Drug Categories anti-arrhythmia agents

    • Version: 01-August-2011

    Alternate Names:
    DESLANOSIDE Primary Drug Name

    Drug Info:
    Drug Class anti-arrhythmia agents
    Drug Class cardiotonic agents
    Year of Approval approved before 1982

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications Antiarrhythmia Agents
    Drug Indications Cardiotonic Agents
    Drug Class small molecule

    Publications:

    • Version: 09-Feb-2016

    Alternate Names:
    DESLANATOSIDE C Drug Synonym
    DESLANOSIDUM C Drug Synonym
    DESLANOSIDE pubchem_primary_name

    Drug Info:

    Publications:

    • Version: 4.3.02 (25-August-2011)

    Alternate Names:
    CID28620 Drug Synonym
    DESACETYL-LANATOSIDE C Drug Synonym
    11029-69-9 Drug Synonym

    Drug Info:

    Publications:

    • Version: 27-September-2017

    Alternate Names:
    DESLANOSIDE GuideToPharmacology Ligand Name
    178103412 PubChem Drug SID

    Drug Info:

    Publications:

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications: